Plex Pharmaceuticals, Inc

Plex Pharmaceuticals, Inc., based in San Diego, CA, is a scientifically-driven company focused on enhancing the lives of patients with complex diseases, particularly neurodegenerative disorders such as Parkinson's disease and glioblastoma. Their innovative drug discovery programs target misfolded proteins and employ cutting-edge technologies to develop therapies that address these pressing health challenges.

In addition to their neurodegenerative research, Plex is working on non-surgical treatments for cataracts, which contribute significantly to global blindness, and has initiated efforts to develop inhibitors for CNS refractory tumors. By employing a unique fragment-based drug discovery approach, Plex aims to expedite the identification of new chemical entities that exhibit potential therapeutic efficacy.

Generated from the website